Semaglutide, however, works by controlling appetite and helping people feel full faster, which can lead to weight loss
According to FDA prescribing information, eructation (the medical term for burping) occurs in approximately 3% of patients taking the 0.5 mg dose of injectable semaglutide and about 1% at the 1 mg dose
Our team of healthcare professionals will work with you to develop a personalized plan that includes the use of semaglutide injections and other strategies to support your weight loss efforts
Methods Adults ( 18 years old) with T2D required at least one prescription for injectable semaglutide at index date (treatment switch), at least one prescription for any other GLP-1 RA in the previous 365 days, a baseline HbA1c and/or weight measurement in the 90 days pre-index and a follow-up measurement at 180 and 365 days post-index
Potential Eye Health Risks While GLP-1 agonists have been heralded as life-changing for some individuals, recent studies and case reports suggest a connection between these drugs and certain eye health complications, particularly diabetic retinopathy and other forms of vision impairment